Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Chorzow – page 17

1 198 clinical trials in Chorzow, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Chorzow at a glance
1 198
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 198 trials in Chorzow

Open in trial search

NHS7108 for Exocrine Pancreatic Insufficiency in Adult Patients

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Amylase
  • Sponsor:Aimmune Nestle Health Science US R&D LLC

AUR200 for Patients with Generalized Myasthenia Gravis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AUR200
  • Sponsor:Aurinia Pharmaceuticals Inc.

Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Obrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Boehringer Ingelheim Espana S.A.

Obesity

Recruiting

RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Enicepatide
  • Sponsor:F. Hoffmann-La Roche AG

Graves' disease

Recruiting

Long-Term Study of Imeroprubart in Adults With Graves' Disease

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

BMN 333 Versus Vosoritide in Children With Achondroplasia

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:BMN 333
  • Sponsor:Biomarin Pharmaceutical Inc.

Cenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cenegermin
  • Sponsor:Dompe' Farmaceutici S.p.A.

Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

AZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AZD0120
  • Sponsor:AstraZeneca AB

A study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:MB-001
  • Sponsor:Mage Biologics Inc.

A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:IKT-001PRO
  • Sponsor:Inhibikase Therapeutics Inc.

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Chorzow

What the registry says about research in the country

01 Hematologic Oncology

Groundbreaking research focusing on blood cancers and related conditions, including innovative treatments for multiple myeloma, lymphomas, and leukemia.

  • B-cell lymphoma treatments
  • Multiple myeloma therapies
  • Chronic lymphocytic leukemia management

Studies evaluating novel drug combinations and targeted therapies to improve patient outcomes.

02 Dermatology

Clinical research addressing various skin conditions, with particular emphasis on chronic inflammatory skin disorders and their treatment approaches.

  • Atopic dermatitis treatments
  • Vitiligo therapies
  • Acne vulgaris management

Investigating both topical and systemic treatments for enhanced therapeutic outcomes.

03 Cardiovascular Medicine

Studies exploring treatments for atherosclerotic cardiovascular disease and acute coronary syndrome, focusing on innovative therapeutic approaches.

  • Lipid-modifying therapies
  • Coronary intervention studies
  • Cardiovascular risk management

Research aimed at reducing major adverse cardiovascular events and improving patient care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.